fda tirzepatide compounding ban on compounded tirzepatide: Switch to name brand medications Zepbound vs Compounded Tirzepatide Side-by-Side
Description
doi: 10.1056/NEJMoa2413258 This article has been republished from the following materials
Patients using tirzepatide achieved average weight loss of 22% of body weightsignificantly greater than semaglutide's 15% reduction over comparable timeframes
The completion rate of 88.8% at the highest dose indicates that most participants tolerated treatment well despite initial side effects
But for some, especially if the weight loss was rapid, an unexpected side effect can occur: sagging, drooping skin on the face and neck
Clinical Trials on Semaglutides Efficacy and Side Effects: Doe, J., Smith, A., & Liu, C
